Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection.Published in:Clinical Medicine Insights: Women's Health, 2014, n. 7, p. 1, doi. 10.4137/CMWH.S10353By:McConville, Christopher;Boyd, Peter;Major, IanPublication type:Article